Bexarotene 75 mg/1 (Bexarotene CAPSULE, LIQUID FILLED) 75 mg/1

Bexarotene 75 mg/1 is a medication used for managing certain skin conditions. This liquid-filled capsule is designed for oral administration and is manufactured by Actavis Pharma, Inc. in the USA.

Strength

75 mg/1

Pack Size

100 CAPSULE, LIQUID FILLED in 1 BOTTLE (0591-2832-01)

Manufacturer / TM Owner

Actavis Pharma, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Bexarotene 75 mg/1 is primarily used for the treatment of cutaneous T-cell lymphoma, a type of skin cancer. It works by targeting specific receptors in the skin to help manage symptoms. Patients often wonder, 'What is bexarotene used for?' and the answer lies in its ability to address severe skin conditions that do not respond to other treatments.

Side Effects

Common effects of bexarotene 75 mg/1 may include skin irritation, headaches, and changes in blood lipid levels. Some users also report fatigue or nausea. These effects can vary widely among individuals and are not experienced by everyone who takes the medication.

Precautions & Warnings

Bexarotene 75 mg/1 should be handled with care, especially by pregnant women or those planning to become pregnant, as it may cause harm to an unborn child. It is important to follow the advice of a healthcare provider regarding its use. Always store the medication as directed to maintain its effectiveness.

Avoid Interactions

Bexarotene 75 mg/1 may interact with other medications, including those that affect liver enzymes. Alcohol and certain supplements can also influence its effectiveness. It is advisable to discuss all current medications with a healthcare provider before starting bexarotene.

Frequently Asked Questions

Bexarotene is primarily used to treat cutaneous T-cell lymphoma, a type of skin cancer.

Bexarotene 75 mg/1 is taken orally, typically in the form of a liquid-filled capsule.

Common side effects may include skin irritation, headaches, and changes in blood lipid levels.

Bexarotene may interact with other medications, so it is important to consult a healthcare provider before combining it with other treatments.

Bexarotene should be used with caution during pregnancy, as it may cause harm to an unborn child.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.